For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $1.01 in the prior trading day, Rockwell Medical Inc (NASDAQ: RMTI) closed at $0.99, down -2.43%. In other words, the price has decreased by -$2.43 from its previous closing price. On the day, 0.72 million shares were traded. RMTI stock price reached its highest trading level at $1.015 during the session, while it also had its lowest trading level at $0.9649.
Ratios:
Our goal is to gain a better understanding of RMTI by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.84 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.66. For the most recent quarter (mrq), Quick Ratio is recorded 2.51 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 0.46 whereas as Long-Term Debt/Eq ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On June 24, 2019, Piper Jaffray started tracking the stock assigning a Overweight rating and target price of $10.
On May 13, 2019, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on May 13, 2019, with a $11 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 01 ’25 when Hunter Heather sold 2,868 shares for $1.19 per share. The transaction valued at 3,413 led to the insider holds 135,391 shares of the business.
Neri Jesse bought 886 shares of RMTI for $1,017 on Oct 01 ’25. On Oct 01 ’25, another insider, Chole Timothy, who serves as the SVP and CCO of the company, sold 2,868 shares for $1.19 each. As a result, the insider received 3,413 and left with 125,299 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMTI now has a Market Capitalization of 33931112 and an Enterprise Value of 29516112. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 1.12. Its current Enterprise Value per Revenue stands at 0.336 whereas that against EBITDA is 32.942.
Stock Price History:
The Beta on a monthly basis for RMTI is 1.62, which has changed by -0.78709674 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, RMTI has reached a high of $5.15, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is -24.51%, while the 200-Day Moving Average is calculated to be -21.82%.
Shares Statistics:
The stock has traded on average 1.44M shares per day over the past 3-months and 421910 shares per day over the last 10 days, according to various share statistics. A total of 34.43M shares are outstanding, with a floating share count of 28.91M. Insiders hold about 16.02% of the company’s shares, while institutions hold 17.98% stake in the company. Shares short for RMTI as of 1760486400 were 1080810 with a Short Ratio of 0.75, compared to 1757894400 on 1545437. Therefore, it implies a Short% of Shares Outstanding of 1080810 and a Short% of Float of 3.55.
Earnings Estimates
Its stock is currently analyzed by 2.0 different market analysts. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.04 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.17 and -$0.18 for the fiscal current year, implying an average EPS of -$0.17. EPS for the following year is -$0.13, with 2.0 analysts recommending between -$0.09 and -$0.17.
Revenue Estimates
2 analysts predict $16.24M in revenue for. The current quarter. It ranges from a high estimate of $16.8M to a low estimate of $15.69M. As of. The current estimate, Rockwell Medical Inc’s year-ago sales were $28.32MFor the next quarter, 2 analysts are estimating revenue of $17.15M. There is a high estimate of $18.13M for the next quarter, whereas the lowest estimate is $16.17M.
A total of 2 analysts have provided revenue estimates for RMTI’s current fiscal year. The highest revenue estimate was $69.91M, while the lowest revenue estimate was $66.84M, resulting in an average revenue estimate of $68.37M. In the same quarter a year ago, actual revenue was $101.49MBased on 2 analysts’ estimates, the company’s revenue will be $75.89M in the next fiscal year. The high estimate is $81.59M and the low estimate is $70.18M.
